Patient with metastatic renal cell carcinoma, who was treated with tyrosine kinase inhibitor in first and second line of palliative treatment – case report
MUDr. Jiří Navrátil, Ph.D.
Klinika komplexní onkologické péče, Masarykův onkologický ústav, Brno
Disseminated renal cancer is an incurable disease. The fundamental of treatment is targeted therapy with tyrosine kinase inhibitors (TKI). We present a case report of a polymorbid patient with disseminated renal clear cell carcinoma treated with two lines of TKI with a good response to treatment while a good quality of life.
renal cell carcinoma, target therapy, hepatopathy, diabetes mellitus, pazopanib, sunitinib
The full article is only available to subscribers
Become a regular subscriber to our Oncological Review...